|
"liu tw"的相关文件
显示项目 1-10 / 139 (共14页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2025-08-06 |
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019
|
Kee, KM;Chen, CH;Liu, TW;Huang, YH;Hu, JT;Chau, GY;Chen, KH;Chiang, CJ;Lin, CC;Hung, CF;Wang, TE;Huang, SF;Ku, HY;Huang, BS;Ch'ang, HJ;Tseng, HP;Lu, SN |
| 國家衛生研究院 |
2025-04-04 |
Cytotoxicity-guided isolation of elatostemanosides I-VI from Elatostema tenuicaudatum W. T. Wang and their cytotoxic activities
|
Huynh, QDT;Phan, TTT;Liu, TW;Duong, TLT;Hsu, SJ;Kuo, CC;Chu, MH;Wang, YH;Nguyen, TV;Shen, YA;Fan, YJ;Nguyen, DK;Vo, TH;Lee, CK |
| 國家衛生研究院 |
2025-02-06 |
Multicenter prospective first-line helicobacter pylori eradication for localized gastric “Pure” diffuse large B-cell lymphoma
|
Chen, LT;Yeh, KH;Lin, CW;Wang, TE;Wang, MC;Hsiao, CF;Chen, CC;Liou, JM;Wang, HP;Wei, MF;Lee, HW;Shun, CT;Liu, TW;Tien, HF;Wu, MS;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2024-10-11 |
Taiwan nationwide study of first-line ALK-TKI therapy in ALK-positive lung adenocarcinoma
|
Zheng, ZR;Wu, JJ;Chiang, CJ;Chen, T;Chen, KC;Chu, CH;Lin, SY;Yu, SL;Lee, WC;Liu, TW;Chang, GC |
| 國家衛生研究院 |
2024-10 |
Long term outcomes of adjuvant radiation in early-stage breast cancer women with 65 years or older after breast-conserving surgery
|
Lin, SM;Ku, HY;Liu, TW;Ch'ang, HJ |
| 國家衛生研究院 |
2024-07-11 |
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study
|
Tsai, HJ;Shan, YS;Yang, CY;Hsiao, CF;Tsai, CH;Wang, CC;Lin, MT;Ting, CF;Chan, DC;Chen, TH;Yen, CC;Chen, YY;Lin, HY;Yeh, TS;Ho, CL;Shieh, TY;Bai, LY;Hsu, JT;Chen, IS;Chen, LT;Yeh, CN;Liu, TW;Chuang, CH;Wang, TE |
| 國家衛生研究院 |
2023-10 |
Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer
|
Ku, HY;Lin, SM;Wang, CL;Lo, YTC;Chang, CS;Chang, GC;Ch'ang, HJ;Liu, TW |
| 國家衛生研究院 |
2023-06 |
Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics
|
Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C |
| 國家衛生研究院 |
2023-04-25 |
Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: a population study
|
Chien, LH;Tseng, TJ;Chen, TY;Chen, CH;Chen, CY;Jiang, HF;Tsai, FY;Ku, HY;Jiang, SS;Hsiung, CA;Liu, TW;Chang, IS |
| 國家衛生研究院 |
2023-04-11 |
Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized
|
Chiu, YF;Liu, TW;Shan, YS;Chen, JS;Li, CP;Ho, CL;Hsieh, RK;Hwang, TL;Chen, LT;Ch'ang, HJ; Taiwan Cooperative Oncology Group pancreatic cancer study group, |
显示项目 1-10 / 139 (共14页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
